Formulation and Drug Delivery, Specialty Dosage Forms

Formulating an ADC Development Solution

August 02, 2020

Many antibody-drug conjugate therapies are in the pipeline; only a handful have been approved. What are the bottlenecks?

Inovio to Scale-Up Manufacture of Intradermal Delivery Device for its COVID-19 Vaccine

June 24, 2020

Inovio received a $71-million contract from the US Department of Defense to scale up manufacture of its Cellectra smart device to deliver its DNA vaccine.

Intertek Expands Pharma Services Facility

May 01, 2019

Intertek has announced the expansion of its pharmaceutical services laboratory in Melbourn, near Cambridge, UK, through the acquisition of a new 20,000 sq. ft facility.

AstraZeneca Gets Positive EMA Opinion on Respiratory Biologic

November 10, 2017

The EMA’s Committee for Medicinal Products for Human Use has recommended marketing authorization approval for AstraZeneca’s benralizumab, a monoclonal antibody for treating severe asthma.

New Study Challenges Current Theories on Skin Delivery of Macromolecules

November 10, 2017

The authors of the study believe it could have significant implications for the discovery of new dermatological products for major diseases such as psoriasis.

Japanese Agency Supports Daiichi Sankyo’s Genetic Vaccine Platform

October 16, 2017

Through the support of the Japanese agency, Daiichi Sankyo intends to further develop its genetic vaccine platform focused around its new nucleic acid delivery technology.

Formulation of Biologics for Non-Invasive Delivery

October 01, 2017

BioPharm International

There is a lot of interest in delivering biologics via non-invasive routes in attempt to improve patient compliance and convenience.

Lonza Boosts Micronization Capacity with Acquisition

August 07, 2017

Lonza further expands its micronization services with the acquisition of Swiss contract manufacturer, Micro-Macinazione, following its previous $5.5-billion acquisition of dosage form provider, Capsugel.

Amgen: Neulasta Safe for Now; Dose Accuracy of Erenumab a New Focus

July 28, 2016

Amgen discussed the drug-delivery approaches to two of its biologics in a recent second-quarter earnings call.

Enable Injections Completes its High-Volume Injector Manufacturing Facility

June 07, 2016

The wearable devices for the delivery of biologic products are now being manufactured and will be tested in clinical trials in the near future, according to the company.